Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Browse creative work from home business ideas that can help you start earning. Discover the perfect fit for your skills!
18,910 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
A big year can turn a small bet into a striking gain. Here’s how a $5,000 investment in Bloom Energy would look today...
Investors rewarded Meta Platforms after news suggesting a sharper AI-driven monetization strategy and resilient ad de...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...
A Utah-based defamation suit accuses Kevin O’Leary and Fox News of tying two local political groups to the CCP amid o...
What do the revenue paths of Advanced Micro Devices and Intel reveal about the AI era? This guide breaks down how the...
Freelancers face fluctuating paychecks. This guide breaks down a simple, three-bucket budget, real-world numbers, and...
Investors are buzzing about forum energy technologies stock as Q4 results point to improving demand in energy equipme...
Anthropic’s Dario Amodei says culture matters more than code in winning the AI race, dedicating up to 40% of his time...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
As regulators eye crypto privacy tools, the DOJ's push for an October retrial in the Tornado Cash case tests how far ...